Back

AT1a receptors in the subfornical organ increase splenic nerve activity and blood pressure in response to chronic Angiotensin II

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Vascular interventions, thrombosis, and stroke Hypertension, Pulmonary Hypertension ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marialuisa Perrotta

Sapienza University of Rome, Rome (Italy)

6 More presentations in this session

Presentation thumbnail
VASCRAFT: a novel tissue-engineered human vascular graft for coronary artery bypass grafting (CABG)
Miss G. Iraola Picornell (Badalona, Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Role and mechanism of xanthine oxidase in platelet hyperreactivity of hyperuricemia patients
Miss W. Gao (Shanghai, CN)
Presentation thumbnail
β-Hydroxybutyrate directly binds to ANXA2 and suppresses AAA progression by inhibiting macrophage infiltration and vascular smooth muscle cell apoptosis
Ms F. Zheng (CN)
Abstract Slides Video
Presentation thumbnail
Nanoformulated linseed oil differentially modulates ex vivo monocyte inflammation of patients with coronary artery disease: identification of responders and non-responders
Doctor S. Hmadeh (Strasbourg, FR) Professor V. Schini-Kerth (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Recovery from ischemic stroke depends upon a Treg lymphokine-induced meningeal lymphatic growth and drainage
Doctor Y. Bai (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Vascular interventions, thrombosis, and stroke

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Neuroinflammation in hypertension.
27 August 2022
thumbnail
Congress Presentation
Current strength-dependent differences in the acute success results of renal artery radiofrequency ablation; requiring appropriate modes of electrical nerve stimulation
31 August 2025
thumbnail
Congress Presentation
Establishment of a female HFpEF model using Dahl salt-sensitive rats and investigation of sympathetic activation-induced acute exacerbation of HFpEF
31 August 2025
thumbnail
Congress Presentation
RNA interference therapy targeting hepatic angiotensinogen for the treatment of hypertension and cardiovascular disease: a first-in-human and proof-of-concept study
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources